Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3G380R transgenic mice

被引:84
作者
Segev, O
Chumakov, I
Nevo, Z
Givol, D
Madar-Shapiro, L
Sheinin, Y
Weinreb, M
Yayon, A [1 ]
机构
[1] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel
[2] ProChon Biotech Ltd, IL-76114 Rehovot, Israel
[3] Tel Aviv Univ, Dept Clin Biochem, Maurice & Gabriela Goldschleger Sch Dent Med, IL-69978 Tel Aviv, Israel
[4] Tel Aviv Univ, Dept Oral Biol, Maurice & Gabriela Goldschleger Sch Dent Med, IL-69978 Tel Aviv, Israel
关键词
D O I
10.1093/hmg/9.2.249
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Achondroplasia, the most common genetic form of human dwarfism, results from a point mutation (G380R) in the gene for fibroblast growth factor receptor 3 (FGFR-3). Heterozygotes for the mutation share disproportionate, proximal shortening of the limbs, mid-face hypoplasia and relative macrocephaly due to a failure in endochondral ossification, Here we have generated transgenic mice expressing the human mutant FGFR-3 under the transcriptional control of the mouse gene, Mice that are hemizygous for the mutant human gene display disproportionate dwarfism with skeletal phenotypes remarkably similar to those of human achondroplasia. Mice that are homozygous for the transgene suffer from a profound delay in skeletal development and die at birth, similar in that respect to humans homozygous for the achondroplasia mutant gene, Microscopic analysis of long bones demonstrates growth plate morphology compatible with that of human achondroplasia cases, sharing endochondral growth inhibition with restrained chondrocyte proliferation and maturation, penetration of ossification tufts and aberrant vascularization.
引用
收藏
页码:249 / 258
页数:10
相关论文
共 53 条
[1]   CONGENITAL GENERALIZED BONE DYSPLASIAS - A CLINICAL, RADIOLOGICAL, AND EPIDEMIOLOGICAL SURVEY [J].
ANDERSEN, PE ;
HAUGE, M .
JOURNAL OF MEDICAL GENETICS, 1989, 26 (01) :37-44
[2]   PERLECAN, BASAL LAMINA PROTEOGLYCAN, PROMOTES BASIC FIBROBLAST GROWTH FACTOR-RECEPTOR BINDING, MITOGENESIS, AND ANGIOGENESIS [J].
AVIEZER, D ;
HECHT, D ;
SAFRAN, M ;
EISINGER, M ;
DAVID, G ;
YAYON, A .
CELL, 1994, 79 (06) :1005-1013
[3]   THE FGF FAMILY OF GROWTH-FACTORS AND ONCOGENES [J].
BASILICO, C ;
MOSCATELLI, D .
ADVANCES IN CANCER RESEARCH, 1992, 59 :115-165
[4]  
BELLUS GA, 1995, AM J HUM GENET, V56, P368
[5]  
Bonaventure J, 1996, AM J MED GENET, V63, P148, DOI 10.1002/(SICI)1096-8628(19960503)63:1<148::AID-AJMG26>3.0.CO
[6]  
2-N
[7]  
BRINER J, 1991, PATHOL RES PRACT, V187, P271
[8]   Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3 [J].
Colvin, JS ;
Bohne, BA ;
Harding, GW ;
McEwen, DG ;
Ornitz, DM .
NATURE GENETICS, 1996, 12 (04) :390-397
[9]   Control of bone growth by fibroblast growth factors [J].
De Luca, F ;
Baron, J .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1999, 10 (02) :61-65
[10]   Abnormal FGFR 3 expression in cartilage of thanatophoric dysplasia fetuses [J].
Delezoide, AL ;
LasselinBenoist, C ;
LegeaiMallet, L ;
Brice, P ;
Senee, V ;
Yayon, A ;
Munnich, A ;
Vekemans, M ;
Bonaventure, J .
HUMAN MOLECULAR GENETICS, 1997, 6 (11) :1899-1906